Related Experiment Video
Updated: Oct 23, 2025

08:58
Fully Automated Centrifugal Microfluidic Device for Ultrasensitive Protein Detection from Whole Blood
Published on: April 16, 2016
10.7K
Label-free detection of C-Reactive protein using bioresponsive hydrogel-based surface relief diffraction gratings
María Isabel Lucío1, Andy Hernández Montoto1, Estrella Fernández1
1Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, Camino de Vera s/n, 46022 Valencia, Spain.
Biosensors & Bioelectronics
|August 20, 2021
Summary
A novel hydrogel biosensor detects C-Reactive protein (CRP) using surface relief gratings. This smart biosensing system offers selective, label-free detection of CRP, crucial for diagnosing cardiovascular diseases and sepsis.
Area of Science:
- Biomaterials Science
- Optical Sensing Technologies
- Biochemical Analysis
Background:
- Responsive hydrogels with surface relief gratings show promise as optical biosensors.
- Existing hydrogel biosensors have limited specificity for analytes and biomolecules.
- Development of novel hydrogels is crucial for advanced biosensing applications.
Purpose of the Study:
- To develop a novel biosensing system utilizing bioresponsive hydrogels and surface relief gratings.
- To create a hydrogel capable of specifically recognizing and detecting C-Reactive protein (CRP).
- To demonstrate label-free detection of CRP in human serum using a laser-based optical setup.
Main Methods:
- Fabrication of micro-gratings on CRP-sensing hydrogel substrates using Direct Laser Interference Patterning.
- Development of a homemade laser-based optical setup for label-free CRP detection.
- Application of amplification strategies to enhance biosensor sensitivity and performance.
Main Results:
- The CRP-sensing hydrogel selectively detected CRP with limits of detection (LOD) and quantification (LOQ) of 1.07 mg L⁻¹ and 8.92 mg L⁻¹, respectively.
- Amplification strategies improved sensitivity, achieving LOD of 0.30 mg L⁻¹ and LOQ of 4.36 mg L⁻¹.
- The biosensing system demonstrated high accuracy with ~100% recovery in certified human serum samples.
Conclusions:
- The developed biosensing system enables selective, label-free detection of CRP at clinically relevant concentrations.
- The system shows potential for early diagnosis of cardiovascular diseases and sepsis.
- The use of bioresponsive hydrogels and surface relief gratings offers a versatile platform for advanced biosensing.

